Dosidal · Switzerland
Agamree, Suspension zum Einnehmen
Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.
| Market | Switzerland |
|---|---|
| Record | ch:authorisation:69650 (version 1) |
| Level | authorisation |
| Pack code | not anchored |
| Identifiers | swissmedic-authorisation: 69650 atc: H02AB18 |
| Source authority | Swissmedic |
| Read date | |
| authorisation status | first_authorisation: 2026-01-14 term: zugelassen valid_until: 2031-01-13 state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page |
| identity | atc: H02AB18 authorisation_number: 69650 form: SUOR holder: Santhera Pharmaceuticals (Schweiz) holder_partner_nr: 1002326 it_number: 01.99.0. name: Agamree, Suspension zum Einnehmen state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page |
| Signature | ES256 over JCS, key dosidal-record-1.9dbf5d53rU_kw-FANiDzsQCUKCaJ9bcRXFy3hpQyWDk3E-kjN3Dbv4eD7FPTnfYEEEo6n1ntpAt5Ofl_6U700cPzVcFg0AVerify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json |
JSON: https://dosidal-api.ai/v1/records/ch:authorisation:69650 · Related records in other markets · Dosidal